Medicare Enrolled

Dr. Katelyn McGlaughlin

Nurse Practitioner - Primary Care · Fort Myers, FL
Low-engagement
8260 GLADIOLUS DR, Fort Myers, FL 33908
2394375755
In practice since 2024 (1 years)
NPI: 1366295552 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McGlaughlin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McGlaughlin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McGlaughlin

Dr. Katelyn McGlaughlin is a nurse practitioner - primary care in Fort Myers, FL, with 1 year of NPI registration.

Between the years covered by Open Payments, Dr. McGlaughlin received a total of $1,459 from 26 pharmaceutical and/or device companies across 62 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - primary care. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McGlaughlin is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 1 years in practice $1,459 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$1,459
Total received (2024-2024)
Top 19% in FL for nurse practitioner - primary care
26
Companies
62
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,327 (91.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$132 (9.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,459

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$163
Incyte Corporation
$132
Merck Sharp & Dohme LLC
$123
AstraZeneca Pharmaceuticals LP
$115
PFIZER INC.
$114
Takeda Pharmaceuticals U.S.A., Inc.
$106
Janssen Biotech, Inc.
$79
Agios Pharmaceuticals, Inc.
$53
Sumitomo Pharma America, Inc.
$52
Bayer Healthcare Pharmaceuticals Inc.
$50
Celgene Corporation
$46
Genmab U.S., Inc.
$42
Alexion Pharmaceuticals, Inc.
$41
Exelixis Inc.
$38
Ipsen Biopharmaceuticals, Inc
$36
ARRAY BIOPHARMA INC
$35
JAZZ PHARMACEUTICALS INC.
$34
Gilead Sciences, Inc.
$28
Blueprint Medicines Corporation
$27
Novartis Pharmaceuticals Corporation
$27
Legend Biotech USA Inc.
$24
Pharmacosmos Therapeutics Inc.
$24
GlaxoSmithKline, LLC.
$23
PUMA BIOTECHNOLOGY, INC.
$18
ABBVIE INC.
$16
SOBI, INC
$14
Top 3 companies account for 28.6% of total payments
Associated products mentioned in payments ›
ALUNBRIG · AYVAKIT · BRAFTOVI · CABOMETYX · CARVYKTI · COSELA · DARZALEX · DOPTELET · ENHERTU · EPKINLY · Enhertu · Epkinly · FRUZAQLA · HYQVIA · IBRANCE · IMFINZI · INLYTA · JAKAFI · KEYTRUDA · MONJUVI · NINLARO · OJJAARA · ORGOVYX · Onivyde · PLUVICTO · REBLOZYL · RYBREVANT · Stivarga · TECVAYLI · ULTOMIRIS · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a nurse practitioner - primary care in Fort Myers?
Compare nurse practitioner - primary cares in the Fort Myers area by procedure volume, costs, and industry payment transparency.
Browse nurse practitioner - primary cares nearby

Geographic Context

Nurse practitioner - primary cares within 10 mi
30
Per 100K population
3.8
County median income
$73,099
Nearest hospital
PARK ROYAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. McGlaughlin is a nurse practitioner - primary care, with low-engagement industry engagement in the top 19% of FL peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. McGlaughlin receive payments from pharmaceutical companies?
Yes. Dr. McGlaughlin received a total of $1,459 from 26 companies across 62 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. McGlaughlin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →